Document 0113 DOCN M95B0113 TI Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity. DT 9511 AU Ferbas J; Kaplan AH; Hausner MA; Hultin LE; Matud JL; Liu Z; Panicali DL; Nerng-Ho H; Detels R; Giorgi JV; Department of Medicine, School of Medicine, University of; California at Los Angeles, USA. SO J Infect Dis. 1995 Aug;172(2):329-39. Unique Identifier : AIDSLINE MED/95348528 AB Persons infected with human immunodeficiency virus (HIV) for > 8 years were studied to delineate virologic and immunologic attributes of long-term survival. Whereas those with 300-700 CD4+ cells/microL often had circulating cytotoxic T lymphocytes (CTL) against HIV antigens, those with > 1000 CD4+ cells/microL did not. The subjects with > 1000 CD4+ cells/microL had low virus burden, low levels of Gag-specific CTL precursors, and minimal CD8+ cell activation. Overall, elevated levels of CD8+ cells, CD38 antigen expression on CD8+ cells, and anti-HIV functions were correlated with increased virus burden, provirus load, and HIV plasma RNA levels. A factor that suppressed HIV replication was spontaneously secreted from CD8+ cells of most subjects but not from those with high CD4+ cell counts. CD8+ cell activities, therefore, may reflect chronic viral stimulation of the immune system. Long-term survivors with high levels of CD4+ cells maintained control of viral replication but lacked the CD8+ cell activities. DE Antibodies, Viral/IMMUNOLOGY Antigens, CD/BIOSYNTHESIS Antigens, Differentiation/BIOSYNTHESIS Comparative Study CD4 Lymphocyte Count CD4-Positive T-Lymphocytes/*VIROLOGY CD8-Positive T-Lymphocytes/*IMMUNOLOGY DNA, Viral/ANALYSIS Follow-Up Studies Human HIV/*ISOLATION & PURIF HIV Seropositivity/IMMUNOLOGY/*VIROLOGY HLA-DR Antigens/BIOSYNTHESIS Lymphocyte Count Lymphocyte Transformation Male Nucleosidases/BIOSYNTHESIS Receptors, Antigen, T-Cell/IMMUNOLOGY RNA, Viral/ANALYSIS Support, U.S. Gov't, P.H.S. Survival Rate Survivors T-Lymphocytes, Cytotoxic/IMMUNOLOGY Viral Interference/IMMUNOLOGY Virus Cultivation Virus Replication/IMMUNOLOGY JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).